RISEDRONATE-WGR risedronate sodium (as hemipentahydrate) 150mg tablet blister pack

Kraj: Australia

Język: angielski

Źródło: Department of Health (Therapeutic Goods Administration)

Składnik aktywny:

risedronate sodium hemipentahydrate, Quantity: 173.4 mg

Dostępny od:

GM Pharma International Pty Ltd

INN (International Nazwa):

Risedronate sodium hemipentahydrate

Forma farmaceutyczna:

Tablet, film coated

Skład:

Excipient Ingredients: lactose; hyprolose; hypromellose; crospovidone; titanium dioxide; magnesium stearate; colloidal anhydrous silica; macrogol 8000; monobasic sodium phosphate dihydrate; dibasic sodium phosphate; indigo carmine aluminium lake; monobasic sodium phosphate monohydrate

Droga podania:

Oral

Sztuk w opakowaniu:

3, 4, 1, 2

Klasa:

Medicine Registered

Typ recepty:

(S4) Prescription Only Medicine

Wskazania:

The treatment of osteoporosis,The treatment of glucocorticoid-induced osteoporosis,The preservation of bone-mineral density in patients on long term corticosteroid therapy

Podsumowanie produktu:

Visual Identification: Blue, round, biconvex coated tablet. Engraved "APO" on one side, "RIS" over "150" on the other side; Container Type: Blister Pack; Container Material: PVC/PVDC; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Status autoryzacji:

Licence status A

Data autoryzacji:

2012-03-08